NCT02421705 - Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome) | Biotech Hunter

Enrollment

99,999,999

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

January 31, 2099

Study Completion Date

January 31, 2099

Conditions

IBSUlcerative Colitis, ActiveUlcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms)Healthy ControlsCrohn's Disease, ActiveCrohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)

Interventions

OTHER

Sample collection

Collection of blood, feces samples, sample of nasal mucosa and biopsies (rectum and colon descendens), questionnaires and performance of rectal sensitivity measurement (barostat), MR scan of brain and transit measurement of colon

Trial Locations (1)

3000

RECRUITING

University Hospitals Leuven, Leuven

All Listed Sponsors

lead

KU Leuven

OTHER